Morgan Stanley Finance LLC has filed a new pricing supplement for buffered jump securities with an auto-callable feature, due November 15, 2029. This offering is part of the company's strategy to expand its structured investment products, catering to investors looking for unique risk-reward profiles.
The significance of this filing lies in its potential to attract investors who are willing to accept risks associated with principal at risk securities. The securities are designed to provide returns based on the performance of the S&P 500 Futures Excess Return Index, with a stated principal amount of $1,000 per security.
Background
Morgan Stanley Finance LLC, a subsidiary of Morgan Stanley, operates under the Standard Industrial Classification (SIC) code 6211, which includes security brokers, dealers, and flotation companies. The company is incorporated in Delaware and has its headquarters at 1585 Broadway, New York, NY. Recent filings include multiple pricing supplements and a registration statement, demonstrating an active approach to capital markets.
What the Filing Says
The filing, dated November 12, 2026, outlines the terms of the new securities, stating, "The securities are unsecured obligations of Morgan Stanley Finance LLC and are fully and unconditionally guaranteed by Morgan Stanley." The offering includes a total principal amount of $352,000, with individual securities priced at $1,000.
Impact
This new offering may affect various stakeholders, including investors seeking innovative financial products and competitors in the security brokerage industry. By introducing these structured investments, Morgan Stanley Finance LLC positions itself to capture a segment of the market focused on unique investment opportunities.
What's Next
The filing does not specify what happens next, but it is likely that the securities will be marketed to specific investor groups, particularly those in fee-based advisory accounts. Further filings may follow as the company continues to expand its product offerings.
Read Next
Dominion Energy announces $1.2 billion senior notes issuance
Lakefront Biotherapeutics Launches €50 Million Share Buyback
Coca-Cola Europacific Partners Announces Share Buyback Details
Zenta Group announces $6.47 million at-the-market offering
MapLight Therapeutics Enters $100 Million Sales Agreement
Cyabra, Inc. Secures $15.6 Million in Private Placement










